Lam Soon (Hong Kong) Limited Overview
Lam Soon (Hong Kong) is a Hong Kong-domiciled, Hong Leong Group-controlled manufacturer of branded staple foods and household cleaning products. Most of its sales and production are in Mainland China, while Hong Kong and Macau provide the brand heritage. The Food segment (about 81% of FY2026 revenue) combines premium bakery flour (Golden Statue, American Roses, Royal Sakura, Double Peach), specialty fats for food manufacturers, and consumer edible oils led by Knife, the Hong Kong peanut-oil leader. The Home Care segment (about 19%) is anchored by AXE, Hong Kong's leading dishwashing brand, and is growing in southern China. The company is mature and modestly profitable, with a net margin of 5.8% in FY2026. It has a fortress balance sheet: HK$2.06 billion in cash, no bank debt, and net cash equal to about 77% of market value. It pays dividends that yield roughly 4–5%. The investment case rests on cash returns, a deep valuation discount and possible take-private optionality, rather than on growth.
Company's own description (paraphrased from FY2026 results, note 3)
The Group reports two segments. Food covers the manufacture and distribution of a wide range of food products, including flour, edible oils and specialty fats. Home Care covers the manufacture and distribution of household and institutional cleaning products. All revenue is recognized at a point in time from the sale of goods. There is no service, subscription or licensing revenue (FY2026 results, note 4).
Third-party profiles based on company disclosures give more detail. Food serves both the catering industry and consumers. Home Care products include liquid dishwashing detergent, laundry powder, liquid laundry detergent, fabric softener, floor cleaner and industrial marble cleanser (Morningstar company profile).
Business model and revenue model
Revenue mix: 100% product sales (FY2026: HK$5,063 million, all "sales of goods"). There is no licensing, royalty or recurring service income.
Value chain position: Lam Soon is a midstream processor and brand owner. It buys agricultural commodities (wheat, including directly sourced imported wheat; peanuts; palm and other vegetable oils) and petrochemical inputs (surfactants, plastic packaging resin). It mills, refines, blends and formulates these into branded and customer-specific finished goods, then sells through retail, e-commerce, distributors and key accounts. It does not own upstream farmland or downstream retail.
Economic engine: Gross margins of about 17–23% (FY2022–FY2026) depend on the spread between commodity costs and selling prices. In flour, the company earns a premium through Japanese-style and specialty bakery formulations and technical service. In oil and home care, brand equity drives the premium. Profit is highly sensitive to wheat, oilseed and petroleum-linked input prices. This was shown in FY2023, when wheat costs linked to the Ukraine war cut net profit by 67%, and again in FY2026, when Middle East-driven surfactant and packaging inflation cut Home Care operating profit by 30%.
Tax feature: Flour milling in Mainland China counts as primary processing of agricultural products and is exempt from PRC corporate income tax. Other Mainland subsidiaries pay 25% (FY2026 results, note 6). This structurally supports Food segment after-tax returns.
Customer types and end-markets
| Customer type | Segment | Examples / channel (per FY2026 commentary) |
|---|---|---|
| Industrial bakeries, food manufacturers, larger key accounts, new-retail platforms | Food (Flour, Specialty Fats) | Customer-specific formulations, technical support and co-development; growth is moving from traditional bakery channels to large key accounts and new retail |
| Traditional bakeries and catering | Food | Coverage being optimized; supported by industry events such as the Golden Statue Cup bread competition |
| Retail consumers (supermarkets, e-commerce, O2O) | Food (Edible Oil), Home Care | Knife oils in Hong Kong and Mainland China; AXE in Hong Kong; e-commerce growing |
| Institutional cleaning customers | Home Care | Hotels, central kitchens, restaurant chains and food plants; historic Procleanic line (FY2009 results describe institutional products for food plants, hotels, central kitchens and fast-food chains) |
Geography: Mainland China contributed 86.2% of FY2026 revenue (HK$4,367 million) and Hong Kong and Macau 13.8% (HK$696 million) (FY2026 results, note 3(c)).
Independent characterization
Lam Soon is effectively a Mainland China B2B flour and specialty-fats business with a smaller branded consumer business attached. In Hong Kong it has iconic brands (Knife, AXE) whose market leadership is out of proportion to their revenue weight. The Food segment produces about 83% of segment operating profit. Within Food, the commentary suggests flour and specialty fats are the more resilient profit pool, while edible oil faces stiff price competition. Home Care is the growth engine by revenue (+10% in FY2026) but is the more volatile profit pool. The balance sheet is over-capitalized: cash is about 50% of total assets, which depresses ROE to about 9% despite segment returns that are healthy on invested operating capital.
Strategy
Stated strategy themes (paraphrased from the FY2026 results outlook and review)
-
Sharper prioritization: put resources into fewer, higher-impact opportunities across products, customers and channels.
-
Innovation and customer solutions: strengthen R&D, technical service and co-development, especially integrated flour-plus-specialty-fats solutions for key accounts.
-
Recurring cost competitiveness: make structural savings routine through direct wheat sourcing, wheat-mix and formulation optimization, and process and logistics improvements.
-
Simplification and productivity: simplify structures and processes and raise organizational productivity. FY2026 head-office costs fell 25%.
-
Selective investment under clear hurdles: invest in people, R&D, digitalization, automation and manufacturing capability, subject to strategic and financial hurdles.
-
Brand value over price: in edible oil, compete on quality, health and differentiated benefits rather than price; in Home Care, use differentiated products, channel-specific offerings and disciplined promotion.
The FY2025 themes (FY2025 results, Stock News summary) were selective price adjustments to defend volume and share, flexible procurement, opex discipline, and investment in talent, digital and R&D infrastructure and new product development. The H1 FY2026 themes (interim results) were disciplined margin and cost control, channel management, and selective investment in product development and digital initiatives.
Initiatives in the last 24 months
| Initiative | Timing | Detail | Source |
|---|---|---|---|
| Conghua Home Care plant | Announced (date not confirmed); in construction | RMB337 million new plant expected in FY2026/27; capacity, automation, integrated R&D and manufacturing | TipRanks; FY2026 results |
| Shanghai R&D hub | Launched Q2 2026 | Fundamental ingredient research, formulation control, supplier and institution collaboration, portfolio expansion beyond dishwashing | FY2026 results |
| Qingzhou flour line upgrade | Commissioned in FY2026 | Local premium Japanese-style flour (Royal Sakura, Golden Statue) for North China | FY2026 results |
| Jintan specialty fats upgrades | FY2026 | Broader product capability | FY2026 results |
| Direct imported-wheat sourcing | FY2026 | Structural procurement savings and supply resilience | FY2026 results |
| Knife health range (Hong Kong) | FY2026 | Zero-trans-fat peanut oil and non-GMO canola; Carlos Chan campaign | FY2026 results |
| Knife × General Administration of Sport of China Training Bureau | FY2026 | Strategic collaboration on quality and health positioning | FY2026 results |
| Academic and industry collaborations (edible oil) | FY2026 | Aroma enhancement, nutrition, product stability, edible-oil standards | FY2026 results |
| Golden Statue Cup, HK and Macau regional selection | FY2026 | Pathway for HK and Macau bakers into the iba UIBC 2027 World Championship of Bread China Selection | FY2026 results |
| Home Care cost response | FY2026 | Pricing actions, alternative sourcing, reformulation, promotional discipline | FY2026 results |
| Sustainability commitments | Ongoing | ESG reports published in Annual Reports (for example, the Annual Report 2023 ESG section) | Annual Report 2023 |
Medium-term targets and guidance
Management does not publish quantified medium-term financial targets, revenue or margin guidance. Not publicly disclosed. The FY2026 outlook is qualitative: conditions are expected to stay demanding, with continued price competition, channel shifts, geopolitical uncertainty and commodity volatility.
Products & Services
The company does not publish SKU-level specifications or prices. The catalog below combines disclosed brands (company descriptions syndicated by Simply Wall St, Yahoo Finance and Morningstar) with product facts from the results announcements. Pricing models are not publicly disclosed for any product beyond the fact that all revenue comes from goods sold at a point in time.
Food segment — Flour
| Brand / line | Description | Target customer | Notes / latest development |
|---|---|---|---|
| Golden Statue (金像牌) | Flagship premium bread flour; long-standing core brand in Hong Kong and southern China | Bakeries, industrial bakers, key accounts | FY2026: produced locally in North China after the Qingzhou line upgrade. Lends its name to the "Golden Statue Cup," the China Selection for the iba UIBC 2027 World Championship of Bread; FY2026 added an inaugural Hong Kong and Macau regional selection. |
| American Roses (美玫牌) | Core flour brand for cakes, pastries and general bakery | Bakeries, food service | Named as a core brand in Annual Reports 2007 and 2020 |
| Royal Sakura | Premium Japanese-style flour | Premium bakeries, key accounts | FY2026: Qingzhou upgrade adds premium Japanese-style flour capacity in North China alongside existing East China capacity |
| Double Peach | Flour brand in the portfolio | — | Disclosed brand; positioning not publicly disclosed |
| Customer-specific flours | Customized formulations co-developed with technical service and R&D | Large key accounts and new-retail platforms | FY2026: strong sales and gross-profit growth in customer-specific products, with integrated flour-plus-fats solutions |
Food segment — Specialty Fats
| Line | Description | Target customer | Notes |
|---|---|---|---|
| Specialty and vegetable fats | Bakery and food-manufacturing fats sold alongside flour as integrated solutions | Catering industry, food manufacturers, bakeries | Still a small base. FY2026: selected upgrades at the Jintan plant widened product capability; priorities are customer base, mix and plant utilization. Brand names not publicly disclosed. |
Food segment — Edible Oil
| Brand / line | Description | Target customer | Notes / latest development |
|---|---|---|---|
| Knife (刀嘜) | Flagship consumer edible-oil brand, launched in 1948; leader in Hong Kong retail peanut oil (FY2022 results) | Households in Hong Kong and Guangdong | FY2026 Hong Kong launch of a health range: zero-trans-fat peanut oil and zero-trans-fat non-GMO canola oil, backed by a brand campaign with Carlos Chan. In Mainland China, a strategic collaboration with the Training Bureau of the General Administration of Sport of China supports the brand's quality and health positioning. |
| Red Lantern (紅燈) | Edible oil brand; repositioned around a health-food image (FY2010 results) | Consumers | Core brand historically (Annual Report 2007); current scale not disclosed |
| Soon | Disclosed brand in the oil and food portfolio | — | — |
Home Care segment
| Brand / line | Description | Target customer | Notes / latest development |
|---|---|---|---|
| AXE (斧頭牌) | Flagship dishwashing liquid, introduced in 1969; Hong Kong market leader in dishwashing; also sold in adjacent categories | Households in Hong Kong and southern China | Named a Hong Kong Top Ten Brand (2000). FY2023: AXE Supra launched in the super-concentrated dishwashing segment. FY2026: leadership held despite heavy promotional competition; selective expansion into adjacent categories. |
| Labour | Detergent brand | Value-conscious households | Core brand historically (Annual Report 2007) |
| Procleanic | Institutional and professional cleaning range | Food plants, hotels, central kitchens, restaurant and fast-food chains | Institutional products described in FY2009 results; current scale not disclosed |
| Product types | Liquid dishwashing detergent, laundry powder, liquid laundry detergent, fabric softener, floor cleaner, industrial marble cleanser | Households and institutions | Morningstar company profile |
| Pipeline | Portfolio expansion beyond dishwashing, supported by the Shanghai R&D hub (Q2 2026) and the Conghua plant (under construction) | — | FY2026 results |
Discontinued lines
| Line | Status | Source |
|---|---|---|
| Manuka honey distribution (China) | Ended 30 June 2022 when the agency agreement expired; described as very small with minimal profit impact | FY2022 results |
| Frozen food division (Lam Soon Food Industries era) | Historical; not part of current reporting | Annual Report 2000 |
| Telecom and internet diversification (1990s) | Exited after the Hong Leong takeover | Bamboo Works |
Financial Narrative
Income statement headline
Sources: final results announcements FY2022, FY2023 and FY2026; Annual Report 2024 five-year summary; FY2025 results (Stock News, 16 Sep 2025). FY2024 gross profit is derived from the disclosed 10% growth in FY2025 gross profit to HK$1,119 million. Diluted EPS equals basic EPS because there were no dilutive instruments (FY2026 note 8).
Revenue CAGR: FY2022–FY2026 −4.6% p.a.; FY2021–FY2026 −2.5% p.a. (FY2021 revenue HK$5,761 million). Both derived.
Longer earnings and dividend context: notes and sources
Sources: Annual Report 2023 five-year summary (FY2019–FY2023); Annual Report 2024; FY2025 and FY2026 results.
Detailed P&L
Historical pre-tax profit: FY2019 HK$398 million; FY2020 HK$400 million; FY2021 HK$421 million; FY2022 HK$285 million; FY2023 HK$90 million (Annual Report 2023).
Commentary. Earnings have followed commodity cycles more than demand cycles. FY2022 revenue peaked at HK$6.1 billion because commodity pass-through inflated prices, but gross margin fell to 18.7% as costs outran pricing. FY2023 was the trough: wheat costs tied to the Ukraine war, weaker volumes and a weaker RMB cut revenue 16% and net profit 67% to HK$85 million (profit warning 31 Jul 2023). The recovery in FY2024–FY2025 came from margin rather than volume. Revenue kept declining, but cheaper wheat and oil, flexible procurement and opex control lifted gross margin to 23.2% and net profit to HK$303 million in FY2025, up 51% (FY2025 results). FY2026 marks an inflection to top-line growth (+5% reported, +2% constant currency). However, S&D spending rose 7%, other income fell (lower FX gains and no dividend income) and Home Care inputs inflated, so operating profit fell 3%. Lower head-office costs (HK$49.6 million versus HK$65.8 million) partly offset these pressures.
Balance sheet
Source: FY2026 results, consolidated statement of financial position. Total assets derived as non-current plus current assets.
Sources: interim and final results announcements (FY2021: interim FY2022; FY2022: interim FY2023; FY2023: interim FY2024). Total equity was HK$2,477 million at June 2020 and HK$2,881 million at June 2021 (FY2021 results). Cash at 31 December 2023 was HK$1,544 million.
Cash composition (30 Jun 2026): about 40% HKD, 36% RMB, 24% USD. Undrawn bank facilities: HK$400 million (FY2025: HK$589 million). Equity-to-debt ratio: 100:0 (FY2026 results).
Cash flow
Operating cash flow and free cash flow: not disclosed in the preliminary announcement; the full cash flow statement will be in the Annual Report 2026. FY2026 dividends paid comprise the FY2025 final (HK$77.4 million) plus the FY2026 interim (HK$35.2 million). FY2025 dividends paid comprise the FY2024 final (HK$63.4 million at HK$0.27) plus the FY2025 interim (HK$35.2 million). There was no company buyback in FY2026; the only share purchases were 229,000 shares bought by the share-scheme trustee for about HK$2.56 million.
Implied cash generation. Cash rose HK$143 million in FY2026 after HK$129 million of capex, HK$113 million of dividends and HK$3 million of trust share purchases. This implies operating cash flow of roughly HK$390 million before FX translation effects on cash, which cannot be isolated from the announcement. It is consistent with EBITDA of about HK$420 million and a modest working-capital build: receivables rose HK$123 million, mostly "other receivables, deposits and prepayments," which may include Conghua construction deposits.
Ratios (derived from FY2026 results unless stated)
ROIC is defined as profit from operations minus interest income, taxed at the effective rate, divided by equity plus lease liabilities minus cash. Interest coverage is not meaningful because the only finance cost is lease interest. The inventory-day improvement from 81 to 70 days is a notable FY2026 working-capital gain.
Trend commentary. Profitability is constrained by over-capitalization rather than weak operations. Excluding cash, the business earned about 18–21% post-tax on invested capital in FY2025–FY2026, an attractive return for a commodity processor. Cash yields about 2.4% (HK$48 million of interest on about HK$2 billion), and holding it pulls group ROE down to about 9%. Liquidity is extremely strong (current ratio about 4.7x), and gearing is nil.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Segment | FY2021 | FY2022 | FY2023 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Food revenue (HKD Mn) | 4,957 | 5,284 | 4,326 | 3,947 | 4,089 |
Home Care revenue (HKD Mn) | 805 | 823 | 793 | 883 | 974 |
Group revenue (HKD Mn) | 5,761 | 6,107 | 5,119 | 4,829 | 5,063 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment and Segment Margins & Growth (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
Food profit from operations (HKD Mn) | 293.1 | 298.8 |
Home Care profit from operations (HKD Mn) | 87.5 | 61.3 |
Total segment profit (HKD Mn) | 380.6 | 360.0 |
Food operating margin (%) | 7.4 | 7.3 |
Home Care operating margin (%) | 9.9 | 6.3 |
Food share of revenue (%) | 81.7 | 80.8 |
Home Care share of revenue (%) | 18.3 | 19.2 |
Food share of segment profit (%) | 77.0 | 83.0 |
Results by Segment and Segment Margins & Growth (%) (FY2021–FY2026)
| Metric | FY2021 | FY2022 | FY2023 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Home Care profit from operations (HKD Mn) | 86 | 55 | 73 | 88 | 61 |
Home Care operating margin (%) | 10.7 | 6.7 | 9.2 | 9.9 | 6.3 |
Segment Margins & Growth (%)
| Metric | FY2022 | FY2023 | FY2026 |
|---|---|---|---|
Food revenue growth (%) | 7 | -18 | 4 |
Home Care revenue growth (%) | 2 | -4 | 10 |
Home Care operating profit growth (%) | -36 | 33 | -30 |
Revenue by Segment (Half-Yearly)
| Metric | H1 FY2025 | H2 FY2025 | H1 FY2026 | H2 FY2026 |
|---|---|---|---|---|
Group revenue (HKD Mn) | 2,681 | 2,148 | 2,670 | 2,393 |
Food revenue (HKD Mn) | 2,208 | 1,739 | 2,170 | 1,919 |
Home Care revenue (HKD Mn) | 468 | 415 | 495 | 479 |
Food operating profit (HKD Mn) | 195 | 98 | 184 | 115 |
Home Care operating profit (HKD Mn) | 55 | 33 | 40 | 21 |
Profit for the period (HKD Mn) | 188 | 115 | 176 | 117 |
Segment Assets & Liabilities
| Metric | FY2025 | FY2026 |
|---|---|---|
Food segment assets (HKD Mn) | 2,216 | 2,270 |
Home Care segment assets (HKD Mn) | 330 | 398 |
Food segment liabilities (HKD Mn) | 484 | 519 |
Home Care segment liabilities (HKD Mn) | 153 | 197 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 6,107 | 5,119 | 4,838 | 4,829 | 5,063 |
Gross profit (HKD Mn; FY2024 derived) | 1,143 | 876 | 1,017 | 1,119 | 1,160 |
Profit for the year (HKD Mn) | 257 | 85 | 201 | 303 | 293 |
Basic EPS (HKD) | 1.09 | 0.36 | 0.85 | 1.29 | 1.25 |
Diluted EPS (HKD) | 1.09 | 0.36 | 0.85 | 1.29 | 1.25 |
Dividend per share (HKD) | 0.48 | 0.30 | 0.40 | 0.48 | 0.50 |
Gross margin (%) | 18.7 | 17.1 | 21.0 | 23.2 | 22.9 |
Net margin (%) | 4.2 | 1.7 | 4.2 | 6.3 | 5.8 |
Revenue growth (%) | 6.0 | -16.2 | -5.5 | -0.2 | 4.8 |
Income Statement and Per-Share Data (FY2019–FY2026)
| Metric | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
Revenue (HKD Mn) | 5,316 | 5,119 | 5,761 | 6,107 | 5,119 | 4,838 | 4,829 | 5,063 |
Profit for the year (HKD Mn) | 340 | 317 | 358 | 257 | 85 | 201 | 303 | 293 |
Dividend per share (HKD) | 0.44 | 0.45 | 0.48 | 0.48 | 0.30 | 0.40 | 0.48 | 0.50 |
Income Statement
| Line item | FY2025 | FY2026 |
|---|---|---|
Revenue (HKD Mn) | 4,829.2 | 5,063.1 |
Cost of sales (HKD Mn) | 3,710.7 | 3,903.3 |
Gross profit (HKD Mn) | 1,118.5 | 1,159.8 |
Other income (HKD Mn) | 70.2 | 54.9 |
Selling and distribution expenses (HKD Mn) | 601.6 | 643.8 |
Administrative expenses (HKD Mn) | 225.7 | 222.0 |
Profit from operations (HKD Mn) | 361.5 | 348.9 |
Finance costs, leases only (HKD Mn) | 0.4 | 0.6 |
Profit before taxation (HKD Mn) | 361.1 | 348.2 |
Taxation (HKD Mn) | 58.1 | 54.9 |
Profit for the year (HKD Mn) | 303.0 | 293.4 |
Depreciation and amortisation (HKD Mn) | 73.2 | 72.8 |
EBITDA = operating profit + D&A (HKD Mn) | 434.7 | 421.7 |
Interest income (HKD Mn) | 48.7 | 48.4 |
EBITDA excluding interest income (HKD Mn) | 386.0 | 373.3 |
Staff costs (HKD Mn) | 486.2 | 501.6 |
Margin Analysis (%)
| Ratio | FY2025 | FY2026 |
|---|---|---|
Gross margin (%) | 23.2 | 22.9 |
Operating margin (%) | 7.5 | 6.9 |
EBITDA margin (%) | 9.0 | 8.3 |
Pre-tax margin (%) | 7.5 | 6.9 |
Net margin (%) | 6.3 | 5.8 |
S&D expenses / revenue (%) | 12.5 | 12.7 |
Admin expenses / revenue (%) | 4.7 | 4.4 |
Effective tax rate (%) | 16.1 | 15.8 |
Balance Sheet
| Metric | FY2025 | FY2026 |
|---|---|---|
Total assets (HKD Mn) | 3,806 | 4,147 |
Cash and deposits (HKD Mn) | 1,916 | 2,059 |
Bank borrowings, short-term (HKD Mn) | 0 | 0 |
Bank borrowings, long-term (HKD Mn) | 0 | 0 |
Lease liabilities, total (HKD Mn) | 12.3 | 17.3 |
Net cash, after leases (HKD Mn) | 1,903 | 2,041 |
Total equity (HKD Mn) | 3,140 | 3,416 |
Intangible assets and goodwill (HKD Mn) | 9.9 | 12.2 |
Property, plant and equipment incl. leasehold land (HKD Mn) | 705.8 | 802.1 |
Inventories (HKD Mn) | 745.1 | 725.3 |
Trade and other receivables (HKD Mn) | 381.4 | 504.3 |
Trade and other payables (HKD Mn) | 595.9 | 640.3 |
Net current assets (HKD Mn) | 2,395 | 2,581 |
Operating working capital, ex-cash (HKD Mn; derived) | 480 | 523 |
Key Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash balance at 30 June (HKD Mn) | 1,485 | 1,541 | 1,457 | 1,916 | 2,059 |
Cash Flow
| Metric | FY2025 | FY2026 |
|---|---|---|
Capital expenditure (HKD Mn) | 59 | 129 |
Dividends paid in the year (HKD Mn; derived from note 7) | 98.6 | 112.6 |
Share purchases by Executive Share Scheme trust (HKD Mn) | 0 | 2.6 |
Increase in cash balance (HKD Mn) | 0 | 143 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2025 | FY2026 |
|---|---|---|
ROE, average equity (%) | 9.6 | 8.9 |
ROA, average or year-end assets (%) | 8.0 | 7.4 |
ROIC, ex-cash, post-tax (%) | 21.2 | 18.4 |
Current ratio (x) | 4.70 | 4.65 |
Debt to equity, bank debt (%) | 0 | 0 |
Net debt / EBITDA (x; net cash shown as negative) | -4.4 | -4.8 |
Interest coverage, operating profit / lease interest (x) | 853 | 555 |
Asset turnover (x) | 1.27 | 1.27 |
Inventory days (company-reported) | 81 | 70 |
Receivable days (company-reported) | 24 | 23 |
Payable days (derived, trade payables / COGS) | 30 | 33 |
Cash conversion cycle (days; derived) | 75 | 60 |
Revenue by Region and Revenue by Region (%)
| Region | FY2025 | FY2026 |
|---|---|---|
Chinese Mainland revenue (HKD Mn) | 4,130 | 4,367 |
Hong Kong and Macau revenue (HKD Mn) | 699 | 696 |
Total revenue (HKD Mn) | 4,829 | 5,063 |
Chinese Mainland share (%) | 85.5 | 86.2 |
Hong Kong and Macau share (%) | 14.5 | 13.8 |
Chinese Mainland growth (%) | 0 | 5.7 |
Hong Kong and Macau growth (%) | 0 | -0.4 |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Recent price | About HK$11.00 (mid-Sep 2026, after results); HK$11.30 (30 Jun 2026) | Bamboo Works; Google Finance |
52-week range (as of 30 Jun 2026) | HK$9.90 – HK$13.00 | Google Finance |
10-year price performance | About HK$8.50 to about HK$11 (+about 30%); total return about +80% including HK$4.28 of cumulative dividends | Bamboo Works, Sep 2026 |
Beta | 0.31 | Snowball Analytics |
Average daily volume | About 2,769 shares | TipRanks |
Analyst coverage | 0 analysts | Simply Wall St |
Valuation Multiples
| Multiple | Lam Soon | Peer reference |
|---|---|---|
P/E (trailing) | 8.8x (HK$11.00 / EPS HK$1.25); Bamboo Works cites about 9x | Arowana about 47x |
P/B | About 0.78x on issued shares (BVPS about HK$14.04) or about 0.76x on outstanding shares; Bamboo Works cites 0.85x (the difference reflects share-count and price basis) | Arowana 1.56x |
EV/EBITDA | About 1.5x (EV about HK$636 million = HK$2,677 million market cap − HK$2,041 million net cash; EBITDA HK$421.7 million) | — |
EV/Sales | About 0.13x | — |
Dividend yield | About 4.5% (HK$0.50 / HK$11.00) | — |
Per-Share Data and Returns & Leverage Ratios (%)
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|
Interim DPS (HKD) | 0.14 | 0.15 | 0.15 | 0.10 | 0.13 | 0.15 | 0.15 |
Final DPS (HKD) | 0.31 | 0.33 | 0.33 | 0.20 | 0.27 | 0.33 | 0.35 |
Total DPS (HKD) | 0.45 | 0.48 | 0.48 | 0.30 | 0.40 | 0.48 | 0.50 |
Basic EPS (HKD) | 1.34 | 1.51 | 1.09 | 0.36 | 0.85 | 1.29 | 1.25 |
Payout ratio (%) | 34 | 32 | 44 | 83 | 47 | 37 | 40 |
Analyst Conclusions
Management guidance
The company gives qualitative guidance only. It expects operating conditions to stay demanding, with price competition, channel shifts, geopolitical uncertainty and commodity volatility. Its response will be sharper prioritization, innovation and customer solutions, recurring cost competitiveness, simplification, and selective investment under explicit hurdles (FY2026 results). No consensus estimates exist because there is no analyst coverage.
Bull case
-
Valuation and cash backing: at about HK$11, net cash covers about 77% of market value, and the operating business trades at about 1.5x EBITDA while earning about 18% post-tax ROIC.
-
Home Care margin rebound and Conghua: Home Care revenue grew 10% in FY2026 while margin fell to 6.3% only because of input costs. A reversion toward the FY2025 margin of 9.9% on HK$974 million of revenue would add about HK$35 million of operating profit, before Conghua efficiencies.
-
Privatization optionality: Hong Leong owns about 60%, the free float is about 27% and the stock trades below book. Three Hong Kong edible-oil peers were taken private between 2020 and 2022, so a premium offer is plausible but unconfirmed.
Bear case
-
Structural revenue erosion: revenue fell from HK$6.1 billion (FY2022) to HK$5.1 billion (FY2026), a CAGR of −4.6%, and constant-currency growth in FY2026 was only 2%.
-
Commodity and geopolitical exposure: profits swing sharply with input costs, from HK$257 million to HK$85 million to HK$303 million between FY2022 and FY2025. FY2026 showed Middle East shocks can cut Home Care profit by 30% within a year.
-
Value trap dynamics: with no catalyst, minimal liquidity, frequent CEO turnover and cash earning only about 2.4%, the discount can persist indefinitely, and a take-private could be priced opportunistically.
Catalysts and monitorables (next 12 months)
| Item | Timing |
|---|---|
| Annual Report 2026 (cash flow statement, compensation, ESG data) | About Oct 2026 |
| AGM vote; FY2026 final dividend HK$0.35 | 11 Nov 2026; payment 3 Dec 2026 |
| H1 FY2027 interim results: Home Care margin trajectory, Mainland demand | About late Feb 2027 |
| Conghua plant commissioning (target FY2026/27) | During FY2027 |
| Petroleum-linked input prices (surfactants, PE/PP resin); wheat and palm-oil prices | Continuous |
| RMB/HKD exchange rate (translation effect on 86% of revenue) | Continuous |
| Any capital-return change (special dividend, buyback) or controlling-shareholder action | Event-driven |
| CEO Lim's first full-year execution record and management bench stability | FY2027 |
Analyst verdict
Lam Soon (Hong Kong) is a well-run but structurally ex-growth staples processor. It is cheap because the market ignores it, not because it is impaired. The operating business is sound. Food holds a resilient 7% operating margin backed by a premium flour franchise, technical-service relationships and a PRC tax exemption. Home Care is gaining share and scale in southern China, even though petroleum-linked inputs halved its second-half profitability in FY2026. Working capital is tightening, capex is being put into productivity (Qingzhou, Jintan, Conghua), and the company has turned back to revenue growth for the first time since FY2022.
The flaw is capital structure and governance rather than operations. Over HK$2 billion of cash earns about 2% and dilutes ROE to under 9%. Free float is thin, institutional ownership is negligible, and three CEOs in about 13 months points to an unresolved leadership model, now settled for the time being on an insider. Dividends are reliable and rising (HK$0.50 in FY2026, a 40% payout, about 4.5% yield), but they absorb only a small share of excess capital.
At about 8.8x earnings, about 0.8x book and about 1.5x EV/EBITDA, investors are paid well to wait for the risk/reward to work. The downside is cushioned by net cash of roughly HK$8.70 per share on the outstanding share count, and upside can come from three directions: normalization of Home Care margins, a higher payout or special distribution, or a take-private by Hong Leong. The last is unconfirmed, but the setup is consistent with the sector's privatization wave.
The key risk is not insolvency but stagnation: years of flat earnings and a persistent discount if commodity shocks keep recurring. For income-oriented, patient, liquidity-tolerant investors, the analyst view is that Lam Soon offers asymmetric value. It is not suited to growth or liquidity-sensitive mandates.
Principal sources: Lam Soon (HK) Final Results Announcements for FY2021, FY2022, FY2023 and FY2026 (HKEX: 23 Aug 2021, 24 Aug 2022, 1 Sep 2023, 7 Sep 2026); Interim Results announcements (Feb 2021, Feb 2022, Feb 2023, 20 Feb 2024); Annual Reports 2000, 2007, 2010, 2020, 2023 and 2024; HKEX announcements of 10 Nov 2022, 31 Jul 2023, 2 Feb 2024, 23 Feb 2024, 17 Apr 2024, 24 May 2024 and 15 Apr 2025; HKEX Disclosure of Interests filings (2003–2006); Lam Soon Food Industries Annual Report 2001; Bamboo Works (15 Sep 2026); FilingReader (7 Sep 2026); Stock News / Tiger Brokers bulletins (16 Sep 2025, 12 Nov 2025, 25 Feb 2026); Simply Wall St; Morningstar; Google Finance; TipRanks; Snowball Analytics; Industrial History of Hong Kong.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure / appointment | Background (as disclosed) |
|---|---|---|---|
KWEK Leng Hai | Chairman (non-executive) | Director since at least 2000; Chairman by 2016 | Qualified Chartered Accountant (Annual Report 2000). Holds 2,300,000 shares (about 0.95%). |
LIM Shueh Hann | Executive Director and CEO | Since 1 May 2025; joined the company in 2014 | Previously General Manager of the Home Care Division, with e-commerce and corporate development experience at the company. Earlier a Senior Analyst in Morgan Stanley's Asia Pacific Financial Institutions Group (Hong Kong), working on US and HK equity capital markets deals. Holds 258,000 shares. Age not disclosed in sources reviewed. (HKEX, 15 Apr 2025) |
Christian K. NOTHHAFT | Non-Executive Director | Since 18 Apr 2024 | Executive Director and CEO of Guoco Group Limited (HKEX-listed). INED of DFI Retail Group. Former CEO of Watsons Personal Care Stores China and MD of Watsons Wine and Fortress Hong Kong. (HKEX, 17 Apr 2024) |
WHANG Yixiang Remus | Non-Executive Director | Since 12 Nov 2025 | Represents the Whang family line (the Whang family holds about 11.3%). Appears to be the appointee described as ED and Group CEO of MC Packaging Pte Ltd, formerly at Evercore and in Guoco Group business development overseeing FMCG assets, with a Wharton BSc in Economics. This mapping is inferred from a summarized bulletin and should be verified against the HKEX announcement of 12 Nov 2025. |
HO Yuk Wai, Joan | Independent NED | On board since at least Feb 2021 | Not detailed in sources reviewed |
CHEUNG Man Ying (Ms.) | Independent NED | Since 12 Nov 2025 | Likely the appointee described as a Fellow, council member (since 2021) and vice president (since 2024) of the Hong Kong Chartered Governance Institute (inferred mapping) |
CHAU Siu Lun | Independent NED | Since 12 Nov 2025 | Likely the appointee described as a solicitor qualified in Hong Kong and England and Wales, partner at Haiwen & Partners, and formerly a partner at Herbert Smith Freehills (2006–2022) and head of its Beijing office (2011–2022) (inferred mapping) |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
23 Feb 2024 (effective 18 Apr 2024) | Wong Cho Fai retires as Group MD/CEO | Board said there was no disagreement and began a search |
17 Apr 2024 (effective 18 Apr 2024 and 15 May 2024) | Nothhaft appointed NED; NED Chew Seong Aun retires | Strengthens the Guoco/Hong Leong link on the board |
24 May 2024 (effective 3 Jun 2024) | James Chiu Chao Hsiang appointed CEO and ED | External hire with nutritional and healthcare products experience |
15 Apr 2025 (effective 1 May 2025) | Chiu resigns to pursue other endeavors; Lim Shueh Hann appointed CEO and ED | Internal successor after an 11-month external tenure, meaning three CEOs in about 13 months |
Aug 2025 | Company secretary changes from Cheng Man Ying to Stella Lo | Approved by written resolution (CG deviation) |
12 Nov 2025 | Whang Sun Tze (NED) retires on age; Lester Huang (INED for 11+ years) does not seek re-election; Whang Yixiang Remus (NED) and two INEDs appointed | Generational and independence refresh |
Major Shareholders
| Holder | Shares | % of issued (243.35M) | Source |
|---|---|---|---|
Hong Leong Company (Malaysia) Berhad, via GuoLine International Ltd | 146,789,659 | 60.3 | Simply Wall St (S&P Capital IQ), Nov 2025 |
Dr. Whang Sun Tze and related parties (Whang & Company, SGR Investment, Raven Investment) | 27,523,743 | 11.3 | Simply Wall St; Bamboo Works cites 11.28% |
Kwek Leng Hai | 2,300,000 | 0.95 | Simply Wall St |
Dimensional Fund Advisors LP | 337,310 | 0.14 | Simply Wall St |
Lim Shueh Hann | 258,000 | 0.11 | HKEX, 15 Apr 2025 |
Lester Garson Huang | 150,000 | 0.06 | Simply Wall St (pre-departure) |
SGR Investment Company Limited | 18,457 | 0.01 | Simply Wall St |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Type | Relative positioning |
|---|---|---|---|
Edible oil (China) | Yihai Kerry Arawana (300999.SZ; Wilmar subsidiary; Arawana/Golden Dragon Fish) | Listed giant | China's largest packaged edible-oil player; scale leader far above Lam Soon |
Edible oil (China) | COFCO (Fortune brand; former listed arm China Agri-Industries privatized 2020) | State-owned | National scale, upstream integration |
Edible oil (China) | Luhua Group (peanut oil) | Private | Peanut-oil specialist and direct rival to Knife in the premium peanut segment |
Edible oil (China) | Changshouhua Food (corn oil; privatized 2020) | Private (formerly listed) | Corn-oil specialist |
Edible oil (Hong Kong) | Hop Hing Group (Lion & Globe; privatized 2022) | Private (formerly listed) | Lam Soon's main Hong Kong edible-oil rival (Bamboo Works) |
Flour (China) | Wudeli Flour Group | Private | — |
Flour (China) | Yihai Kerry Arawana flour; COFCO flour | Listed / state-owned | Scale players in general-purpose flour |
Flour (premium / Japanese-style) | Japanese millers operating in China, such as Nisshin Seifun | Listed (Japan) | — |
Specialty fats | Wilmar / Yihai Kerry; Fuji Oil; Bunge Loders Croklaan | Listed multinationals | Larger, technically deep specialty-fat suppliers |
Home care (China) | Guangzhou Liby (立白); Nice Group (纳爱斯/雕牌); Blue Moon (藍月亮, HKEX 6993) | Private / listed | Dominant domestic detergent and dishwashing brands |
Home care (multinationals) | Procter & Gamble (Joy, Tide/Ariel); Unilever (Sunlight, Omo); Kao; Lion Corporation | Listed | Global scale and marketing budgets; strong presence in Hong Kong retail |
Peer Comparison FY2026
| Company | Latest FY revenue | Revenue growth | Net margin |
|---|---|---|---|
Lam Soon (HK), FY Jun-2026 | HK$5.06bn (about US$0.65bn) | +4.8% | 5.8% |
Yihai Kerry Arawana, FY2024 | About RMB 239bn | — | — |
Wilmar International, FY2024 | About US$67bn | — | — |
Procter & Gamble, FY Jun-2025 | About US$84bn | About flat | — |
Recent Developments
There were no layoffs, litigation or regulatory actions in the period. Headcount fell slightly to about 1,480.



